2nd Circ. Won't Revive Apotex's Unfair Competition Suit
A Second Circuit panel has refused to revive Apotex Corp.'s claims accusing Pfizer unit Hospira of violating unfair competition and other state laws in part by reneging on a promise to...To view the full article, register now.
Already a subscriber? Click here to view full article